Expression of RXFP1 Is Decreased in Idiopathic Pulmonary Fibrosis. Implications for Relaxin-based Therapies.
about
Loss of Twist1 in the Mesenchymal Compartment Promotes Increased Fibrosis in Experimental Lung Injury by Enhanced Expression of CXCL12In search of a small molecule agonist of the relaxin receptor RXFP1 for the treatment of liver fibrosis.Simultaneously Targeting Myofibroblast Contractility and Extracellular Matrix Cross-Linking as a Therapeutic Concept in Airway Fibrosis.Update in Interstitial Lung Disease 2016.Reply: Promise and Limitations of Relaxin-based Therapies in Chronic Fibrotic Lung Diseases.Fibrosis: Lessons from OMICS analyses of the human lung.Impact of Transcriptomics on Our Understanding of Pulmonary Fibrosis.Ubiquitination and deubiquitination emerge as players in idiopathic pulmonary fibrosis pathogenesis and treatment.
P2860
Q37681533-DB3962E1-A31C-4648-B9BB-EF7B4A67EFE7Q41537671-1BB491BE-494B-4EEA-898B-95FCDBF83F97Q48037448-94581D23-8BF0-4F4E-89F3-BDFB4B7310CBQ49734357-72A5B453-DA60-42FD-B456-69384EAFC09CQ50327879-C592D7F3-410C-413A-99EC-C55BAD27142FQ51760494-66C10539-4B86-4FC1-831C-C3F5E433108FQ52578942-54621AE5-2C57-46B4-AF0C-0D1D9E649EF7Q55371625-E750C7E3-9DFA-48A4-A47F-D6F756B58BA9
P2860
Expression of RXFP1 Is Decreased in Idiopathic Pulmonary Fibrosis. Implications for Relaxin-based Therapies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Expression of RXFP1 Is Decreas ...... s for Relaxin-based Therapies.
@en
Expression of RXFP1 Is Decreas ...... s for Relaxin-based Therapies.
@nl
type
label
Expression of RXFP1 Is Decreas ...... s for Relaxin-based Therapies.
@en
Expression of RXFP1 Is Decreas ...... s for Relaxin-based Therapies.
@nl
prefLabel
Expression of RXFP1 Is Decreas ...... s for Relaxin-based Therapies.
@en
Expression of RXFP1 Is Decreas ...... s for Relaxin-based Therapies.
@nl
P2093
P2860
P50
P1476
Expression of RXFP1 Is Decreas ...... s for Relaxin-based Therapies.
@en
P2093
Brenda Juan-Guardela
Humberto Trejo Bittar
Jiangning Tan
John R Tedrow
Kristen L Veraldi
Kritika Ramani
Mehdi Nouraie
Partha S Biswas
Yanxia Chu
Yingze Zhang
P2860
P304
P356
10.1164/RCCM.201509-1865OC
P407
P577
2016-06-16T00:00:00Z